Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Intestinal Neuroendocrine Tumor 1

Interventions

Specimen Handling 481 pembrolizumab 454 Magnetic Resonance Spectroscopy 419 Carboplatin 321 Cyclophosphamide 314 Biopsy 272 Cisplatin 264 Radiotherapy 239 Paclitaxel 226 Gemcitabine 222 Bevacizumab 212 Nivolumab 189 fludarabine 183 venetoclax 172 Drug Therapy 165 Dexamethasone 157 Blood Specimen Collection 156 Oxaliplatin 154 Injections 152 Capecitabine 152 Fluorouracil 144 Docetaxel 142 Standard of Care 136 Radiosurgery 136 Rituximab 125 Pemetrexed 115 durvalumab 113 atezolizumab 110 Leucovorin 110 Radiation 105

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Serum Albumin × 1 year × Clear all

NCT06876532 2025-11-18

LUTIBI

Institut Claudius Regaud

Phase NA Recruiting

Intestinal Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡